QQ客服 官方微博 反馈留言

	Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway
	Peng, Bo; He, Rong; Xu, Qihua; Yang, Yifei; Hu, Qin; Hou, Hongping; Liu, Xinmin; Li, Jianrong
	2019
卷号	142页码:1-13
关键词	20(S)-protopanaxadiol Metastasis Breast cancer EMT EGFR/MAPK pathways
ISSN号	1043-6618
DOI	10.1016/j.phrs.2019.02.003
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6345099
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Peng, Bo,He, Rong,Xu, Qihua,et al. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway[J],2019,142:1-13.
APA	Peng, Bo.,He, Rong.,Xu, Qihua.,Yang, Yifei.,Hu, Qin.,...&Li, Jianrong.(2019).Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.,142,1-13.
MLA	Peng, Bo,et al."Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway".142(2019):1-13.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。